Michael DeBaun

Two factors commonly used to evaluate patients with sickle cell disease are associated with each other and can predict increased mortality, Vanderbilt researchers have discovered. Read More

The National Institutes of Health (NIH) has awarded Vanderbilt’s Department of Pediatrics a K12 training grant to support early career faculty to become physician-scientists, the first time the department has received such an award. Read More

Every day, physicians at Monroe Carell Jr. Children’s Hospital at Vanderbilt are looking for new and effective ways to care for their patients. Often that mission is carried out through clinical, basic and translational research across the institution and disciplines. Read More

Throughout his career in medicine, Michael R. DeBaun, M.D., has found moments to fight the status quo. Read More

Michael R. DeBaun, M.D., J.C. Peterson Professor of Pediatrics and Medicine at Vanderbilt, will be the keynote speaker at the 13th Annual Levi Watkins Jr. Lecture. Read More

Vanderbilt-led research found regular blood transfusion therapy significantly reduces the recurrence of strokes in children with sickle cell anemia who have previously had "silent" strokes. Read More

Michael R. DeBaun, M.D., MPH, has been recognized by the American Society of Hematology (ASH) for his significant contributions and research advances in the area of sickle cell disease. Read More

Vanderbilt University’s Cyndya Shibao, M.D., MSCI, has received a Clinical Scientist Development Award from the Doris Duke Charitable Foundation. Read More

Researchers from the Monroe Carell Jr. Children’s Hospital at Vanderbilt and Aminu Kano Teaching Hospital in Kano, Nigeria, will work on a collaborative project to study a sickle cell disease treatment for children in Nigeria. Read More

Ten Vanderbilt University faculty members who have been named to new endowed chairs were recognized for their remarkable achievements and contributions on Feb. 28. Read More